Development of the “chronic condition measurement guide”: a new tool to measure chronic conditions in older people based on ICD-10 and ATC-codes
- 37 Downloads
Key summary points
To develop a comprehensive open-source measurement guide of the most prevalent chronic conditions among persons aged 65+ based on registry data of both diagnoses and prescribed drugs [“The Chronic Condition Measurement Guide (CCMG)].
Based on the Danish population aged 65 years and older we developed the CCMG identifying 83 different chronic conditions based on registry data of both diagnoses and prescribed drugs. By applying the CCMG to a large national cohort of all Danish citizens aged 65 or above, we found that the prevalence of multimorbidity ranged from 10 to 69% using different years of history and in- or excluding information about drug prescribing.
The CCMG is easily implemented using registry data and we recommend using 10 years of history and drug prescribing information.
The aim of the study was to develop a comprehensive open-source measurement guide of the most prevalent chronic conditions among persons aged 65+ based on registry data of both diagnoses and prescribed drugs [the chronic condition measurement guide (CCMG)]. Furthermore, to investigate proof of concept of the measurement guide, different years of history and in- and excluding data on prescribed drugs. Finally, to investigate the measurement guide with other measurement guides designed to identify chronic conditions in persons aged 65+.
The measurement guide was based on the 200 most prevalent chronic ICD10 codes in the Danish population 65+ years in 2015; the 200 most prevalent chronic ICD10 codes and causes of death in a cohort of 209,337 people who died of non-traumatic causes (January 2011–January 2016). Prescribed drugs were included in the measurement guide based on a literature review and specialist opinions.
We identified 83 different chronic conditions based on 1241 unique ICD-10 codes. Multimorbidity prevalence ranged from 10% (1-year history, excluding prescribing information) to 69% (15-year history, including prescribing information). We identified 95% of the persons with multimorbidity using the 29 most prevalent chronic conditions. Inclusion of these 29 conditions affected the prevalence of multimorbidity and 1-year mortality when the CCMG was compared with other measurement guides.
The CCMG is easily implemented using registry data. When implementing the measurement guide 10 years of history and drug prescribing information should be used. Using the CCMG to study multimorbidity, we recommend using at least the 29 most prevalent chronic conditions.
KeywordsChronic conditions People aged 65+ Multimorbidity Measurement
The Authors like to thank Henrik Hedegaard Klausen MD, PhD, Beata Malmqvist MD, PhD, Ejvind Frausing MD, Ane Kathrine Skielbo MD, PhD, Thomas Huneck Haupt MD, PhD for validating the drugs used in the Chronic Condition Measurement Guide.
Compliance with ethical standards
Conflict of interest
The authors report no conflicts of interest in this work.
This study has been approved by The Data Protection Agency (Project no. 704775 at Statistics Denmark). No approval from The Danish Research Ethics Committees for The Capital Region was needed since only national registry data have been used.
As this is a registry study based on national registers no informed consent exists.
- 4.Willadsen TG, Bebe A, Køster-Rasmussen R, Jarbøl DE, Guassora AD, Waldorff FB et al (2016) The role of diseases, risk factors and symptoms in the definition of multimorbidity—a systematic review. Scand J Prim Health Care 34:112–121. https://doi.org/10.3109/02813432.2016.1153242 CrossRefGoogle Scholar
- 11.Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH et al (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41:237–248. https://doi.org/10.1016/0165-1781(92)90005-N CrossRefGoogle Scholar
- 15.van den Bussche H, Koller D, Kolonko T, Hansen H, Wegscheider K, Glaeske G et al (2011) Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health 11:101. https://doi.org/10.1186/1471-2458-11-101 CrossRefGoogle Scholar
- 16.Calderón-Larrañaga A, Vetrano DL, Onder G, Gimeno-Feliu LA, Coscollar-Santaliestra C, Carfí A et al (2017) Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization. J Gerontol A Biol Sci Med Sci 72:1417–1423. https://doi.org/10.1093/gerona/glw233 Google Scholar
- 17.von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD CrossRefGoogle Scholar
- 20.World Health Organization (2014) International statistical classification of diseases and related health problems 10th revision. Available at: http://apps.who.int/classifications/icd10/browse/2015/en. Accessed 20 Jan 2019
- 21.WHO Collaborating Centre for Drug Statistics Methodology (2017) Guidelines for ATC classification and DDD assignment 2018. World Health Organization, Oslo, Norway. https://www.whocc.no/atc_ddd_index/. Accessed 20 Jan 2019
- 25.Perrin EC, Newacheck P, Pless IB, Drotar D, Gortmaker SL, Leventhal J et al (1993) Issues involved in the definition and classification of chronic health conditions. Pediatrics 91:787–793Google Scholar
- 26.Klausen HH, Petersen J, Bandholm T, Juul-Larsen HG, Tavenier J, Eugen-Olsen J et al (2017) Association between routine laboratory tests and long-term mortality among acutely admitted older medical patients: a cohort study. BMC Geriatr 17:62. https://doi.org/10.1186/s12877-017-0434-3 CrossRefGoogle Scholar
- 28.Vivas-Consuelo D, Usó-Talamantes R, Trillo-Mata JL, Caballer-Tarazona M, Barrachina-Martínez I, Buigues-Pastor L (2014) Predictability of pharmaceutical spending in primary health services using clinical risk groups. Health Policy Amst Neth 116:188–195. https://doi.org/10.1016/j.healthpol.2014.01.012 CrossRefGoogle Scholar
- 31.Pratt NL, Kerr M, Barratt JD, Kemp-Casey A, Kalisch Ellett LM, Ramsay E et al (2018) The validity of the Rx-risk comorbidity index using medicines mapped to the anatomical therapeutic chemical (ATC) classification system. BMJ Open 8:e021122. https://doi.org/10.1136/bmjopen-2017-021122 CrossRefGoogle Scholar
- 35.Johansen, NB, Lykke, MB, Bekker-Jeppesen, M, Buhelt, LP, Allesoe, K, Andreasen, AH, et al. [Sundhedsprofil for Region Hovedstaden og kommuner 2017—Kronisk sygdom. In English: Health profile for the Capitol Region of Denmark and municipalities 2017—Chronic disease] In Danish. Centre for Clinical Research and Prevention, University Hospital of Bispebjerg and Frederiksberg, The Capitol Region of Denmark. 2018. https://www.regionh.dk/fcfs/sundhedsfremme-og-forebyggelse/Documents/Sundhedsprofil_2017_Kronisk%20sygdom.pdf. Accessed 12 Dec 2018